Data accrue on "visionary" agent to interrupt addiction.
作者信息
Morris K
出版信息
Lancet. 1999 Nov 27;354(9193):1883. doi: 10.1016/S0140-6736(05)76849-5.
Abstract
摘要
相似文献
1
Data accrue on "visionary" agent to interrupt addiction.
Lancet. 1999 Nov 27;354(9193):1883. doi: 10.1016/S0140-6736(05)76849-5.
2
100 years of ibogaine: neurochemical and pharmacological actions of a putative anti-addictive drug.
Pharmacol Rev. 1995 Jun;47(2):235-53.
3
[Ibogaine--the substance for treatment of toxicomania. Neurochemical and pharmacological action].
Medicina (Kaunas). 2004;40(3):216-9.
4
The ibogaine medical subculture.
J Ethnopharmacol. 2008 Jan 4;115(1):9-24. doi: 10.1016/j.jep.2007.08.034. Epub 2007 Aug 25.
5
DARK Classics in Chemical Neuroscience: Ibogaine.
ACS Chem Neurosci. 2018 Oct 17;9(10):2475-2483. doi: 10.1021/acschemneuro.8b00294. Epub 2018 Oct 9.
6
Treating drug dependence with the aid of ibogaine: a retrospective study.
J Psychopharmacol. 2014 Nov;28(11):993-1000. doi: 10.1177/0269881114552713. Epub 2014 Sep 29.
7
Evaluating the toxicity and therapeutic potential of ibogaine in the treatment of chronic opioid abuse.
Expert Opin Drug Metab Toxicol. 2021 Sep;17(9):1019-1022. doi: 10.1080/17425255.2021.1944099. Epub 2021 Jun 24.
8
Addiction research. Ibogaine therapy: a 'vast, uncontrolled experiment'.
Science. 2005 Apr 15;308(5720):345-6. doi: 10.1126/science.308.5720.345.
9
Observations on treatment with ibogaine.
Am J Addict. 1998 Winter;7(1):89-90. doi: 10.1111/j.1521-0391.1998.tb00472.x.
10
Ibogaine as a treatment for substance misuse: Potential benefits and practical dangers.
Prog Brain Res. 2018;242:217-257. doi: 10.1016/bs.pbr.2018.08.005. Epub 2018 Oct 12.
Zotero 插件